Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy

Maturitas

Volumn 50, Issue 2, 2005, Pages 98-104

  Palacios, Santiago ^a   Castelo Branco, Camil ^b   Cancelo, María Jesús ^c   Vázquez, Francisco ^d  

^a Instituto Palacios de Salud Y Medicina de la Mujer   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^d Lugo   (Spain)

Author keywords

Hormone therapy; Urogenital symptoms; Vaginal estriol

Indexed keywords

ESTRIOL; ESTROGEN;

ADULT; ARTICLE; ATROPHY; BLOOD ANALYSIS; CLIMACTERIUM; CLINICAL ARTICLE; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; EVALUATION; FEMALE; GYNECOLOGIC DISEASE; HISTORY OF MEDICINE; HORMONAL THERAPY; HUMAN; INFORMED CONSENT; LATENT PERIOD; LOW DRUG DOSE; PAPANICOLAOU TEST; PHYSICAL EXAMINATION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; URINALYSIS; UROGENITAL ATROPHY; VAGINITIS;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVAGINAL; ADULT; ATROPHY; COLPOSCOPY; CONTRACEPTIVE AGENTS, FEMALE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTRIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; TREATMENT OUTCOME; UROLOGIC DISEASES; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINAL DISEASES; VAGINAL SMEARS;

EID: 11844285742     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.04.007     Document Type: Article

References (15)

1. Chan R.C., Reid G., Irvin R.T., Bruce A.W., Coterton J.W. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect. Immun. 47:1985;84-89
2. Robinson D., Cardozo L.D. The role of estrogens in female lower urinary tract dysfunction. Urology. 62(4, Suppl 1):2003;45-51
3. Willhite L.A., O'Connell M.B. Urogenital atrophy: prevention and treatment. Pharmacotherapy. 21:2001;464-480
4. Palacios S, Menendez C. Alteraciones del Tracto Genito Urinario bajo y Menopausia. El climaterio y Menopausia. Madrid: Mirpal; 1992. p. 105-12.
5. Yoshimura T., Okamura H. Short term oral estriol treatment restores normal premenopausal vaginal flora to elderly women. Maturitas. 21:2001;253-257
6. Batra SC, Iosif S. Progesterone receptors in the female lower urinary tract. J Urol 1987;138:1301-4.
7. Raz R., Stamm W.E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infection. N. Engl. J. Med. 329:1993;753-756
8. Semmens J.P., Wagner G. Effects of estrogen therapy on vaginal physiology during menopause. Obstet. Gynecol. 66:1985;15-18
9. Blakeman P.J., Hilton P., Bulmer J.N. Cellular proliferation in the female lower urinary tract with reference to oestrogen status. Br. J. Obstet. Gynaecol. 108:2001;813-816
10. Weber A.M., Walters M.D., Schover L.R., Mitchinson A. Vaginal anatomy and sexual function. Obstet. Gynecol. 86:1995;946-999
11. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2003;(4):CD001500.
12. Santen R.J., Pinkerton J.V., Conaway M., Wisniewski L., Demers L., Klein K.O. Treatment of urogenital atrophy with low dose estradiol: preliminary results. Menopause. 9:2002;179-187
13. Manonai J., Thjeppisai U., Suthutvoravut S., Udomsubpayakul U., Chittacharoen A. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study. J. Obstet. Gynaecol. Res. 27:2001;255-260
14. Pschera B., Hjerpe A., Carltröm K. Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17β and progesterone in postmenopausal women. Gynecol. Obstet. Invest. 27:1989;204-208
15. Manonai J., Thjeppisai U., Chittacharoen A. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms. J. Med. Assoc. Thai. 84:2001;1015-1020